(2,6)-Diamino-(5,7)-dihydroxyheptanoic acid (DADH), a
non-proteinogenic
amino acid, is converted to 1-azabicyclo[3.1.0]hexane ring-containing
amino acids that are subsequently incorporated into ficellomycin and
vazabitide A. The present study revealed that the sugar aminotransferase-like
enzymes Fic25 and Vzb9, with a high amino acid sequence identity (56%)
to each other, synthesized stereoisomers of DADH with (6S) and (6R) configurations, respectively. The crystal
structure of the Fic25 complex with a PLP-(6S)–N
2-acetyl-DADH adduct indicated that Asn45 and
Gln197 (Asn205 and Ala53 in Vzb9) were located at positions that affected
the stereochemistry of DADH being synthesized. A modeling study suggested
that amino acid substitutions between Fic25 and Vzb9 allowed the enzymes
to bind to the substrate with almost 180° rotation in the C5–C7
portions of the DADH molecules, accompanied by a concomitant shift
in their C1–C4 portions. In support of this result, the replacement
of two corresponding residues in Fic25 and Vzb9 increased (6R) and (6S) stereoselectivities, respectively.
The different stereochemistry at C6 of DADH resulted in a different
stereochemistry/orientation of the aziridine portion of the 1-azabicyclo[3.1.0]hexane
ring, which plays a crucial role in biological activity, between ficellomycin
and vazabitide A. A phylogenic analysis suggested that Fic25 and Vzb9
evolved from sugar aminotransferases to produce unusual building blocks
for expanding the structural diversity of secondary metabolites.